See what the world's top investors are buying and saying

This Week's Picks2026-08-03
This week's pulseThis week’s institutional investor letters focus on two themes. First, the divergence between AI concentration and value investing. Hosking Partners notes that AI beneficiary stocks contributed 85% of this year’s market returns, with Nvidia, Micron, Broadcom, and Sandisk expected to contribute 40 percentage points to S&P earnings growth. Baillie Gifford-affiliated funds hold heavy positions in ASML and SpaceX, while SAINTS has only about 14% of its positions in AI, and Oakmark and others continue to defend value investing. Second, geopolitics is back in the capital cycle: Rick Rule is bullish on uranium (Cameco); capital_cycle discusses state intervention with ArcelorMittal as an example; Marathon notes that Japanese buybacks reached approximately 1.4% of TOPIX market capitalization.
Fund family weeklyBG fund family: 88 new documents across 38 fundsAmerican Fund, Cautious Managed Fund, China Fund, China Growth Trust, Developed Asia Pacific Fund, Emerging Markets Growth Fund and 32 more · 38 factsheets, 16 annual reports, 16 interim reports, 11 valuations, 7 literature. Tap for fund timelines.
1171 items
Jul 2026
31 Jul 2026The Capital Cycle (Marathon)Podcast~14 min
Buyback Heaven (July 2026)
Japanese companies are now buying back their own shares on a large scale—using cash to repurchase and cancel stock, so each remaining share earns more. Japan’s exchange now requires companies trading…
Host · Edward ChancellorGuest · Justin HillSource: Podcast transcript
31 Jul 2026The Capital Cycle (Marathon)Podcast~12 min
RealKapital (July 2026)
Governments are now reshaping global steel trade for national security, turning once-competitive markets into ones dominated by a few protected companies. A case in point: ArcelorMittal, a steel giant…
Host · Edward ChancellorGuest · Tytus ZurawskiSource: Podcast transcript
31 Jul 2026Third PointArticle~22 min
Third Point July 2026 Monthly Report
Third Point Master Fund's July 2026 performance shows: net return of -6.0% for the month, and +0.8% year-to-date. Asset allocation is 70% in Third Point Offshore Fund and 30% in Malibu Life Reinsurance SPC. Total net exposure is 92.0% (long 117.4%, short 25.4%). The monthly loss was primarily driven
Source: Fund website
29 Jul 2026Aswath Damodaran (Musings on Markets)Article~29 min
Information Timing and Release: The Gaming of Guidance!
This article looks at two proposals: the SEC's idea to make companies report every six months instead of every quarter, and the new Federal Reserve chair's plan to give less market guidance. The autho…
Source: Fund website
28 Jul 2026Rick Rule (Rule Investment Media)Article~35 min
Uranium poised for second leg upwards — Rule Investment Newsletter #18
This article says nuclear power is making a comeback because AI data centers need huge amounts of electricity and countries want to reduce reliance on imported fossil fuels. Uranium supply is struggli…
Source: Fund website
27 Jul 2026Scottish Mortgage (Baillie Gifford)Podcast~11 min
ASML: The Printing Press of the AI Age
This article explains why ASML, a Dutch company, is so important: it makes the machines (called lithography machines) needed to produce advanced AI chips. No matter which AI company wins—OpenAI, Googl…
Source: Podcast transcript
27 Jul 2026Cobas Asset ManagementQuarterly~45 min
Comment First Semester 2026
This report covers how Spanish asset manager Cobas handled its portfolio in the first half of 2026. It sold energy stocks that had risen a lot (like Saipem) and bought less popular, cheaper companies…
Source: Fund website
24 Jul 2026Baillie GiffordDeep research~6 min
SAINTS spotlight: testing the case for resilient growth
This report from Baillie Gifford is about why they think passive index funds (like ETFs that track the market) are not neutral—they've become too concentrated in AI stocks, ignoring other growth areas…
Source: Fund website
24 Jul 2026Patient Capital ManagementArticle~12 min
2Q26 Quarterly Webinar
This article summarizes a webinar by investment firm Patient Capital. The founder argues that the current US stock market bull run, which started in 2009, is still in the “optimism” phase, not the “eu…
Source: Fund website
23 Jul 2026Oakmark FundsDeep research~4 min
Why the case for value investing remains strong
This article argues value investing is still strong. Over the past decade, value strategies returned 10-11% annually, but tech stocks stole the spotlight. The S&P 500 has become a concentrated tech fu…
Source: Fund website
22 Jul 2026Scottish Mortgage (Baillie Gifford)Podcast~9 min
Portfolio Update Q2 2026
This article explains how Scottish Mortgage Investment Trust, a big tech investor, recently moved its money. They still back SpaceX hard after its IPO, arguing rockets are just the start — future prof…
Source: Podcast transcript
21 Jul 2026Rick Rule (Rule Investment Media)Article~12 min
Paul's Notes #10 — The Poison or the Remedy?
Gold miners dig up gold—the antidote to inflation—but then sell it for cash, which loses value every year. Rick Rule argues they should hold gold instead. He shows that if Barrick Gold had kept its ca…
Source: Fund website
20 Jul 2026Hosking PartnersReport~13 min
Q2 2026 - Quarterly Report Commentary
The market is experiencing one of the biggest momentum rallies in history, with 85% of gains coming from AI-related stocks. Four stocks alone (Nvidia, Micron, Broadcom, Sandisk) are expected to contri…
Author · Omar MalikSource: Fund website
17 Jul 2026Baillie GiffordDeep research~5 min
SpaceX: why US Growth invested at the IPO
SpaceX went public at an eye-popping $1.7 trillion valuation. But Baillie Gifford, a long-time private investor, still bought in. Why? They see real substance: SpaceX launches over 80% of global paylo…
Source: Fund website
16 Jul 2026Hosking PartnersReport~11 min
Fit for Purpose
When choosing a fund, don't just look at the star manager. Research shows that a fund's internal structure—like whether decisions are made by a team of independent managers or a single person—explains…
Author · Luke BridgemanSource: Fund website
16 Jul 2026Baillie GiffordDeep research~5 min
Edinburgh Worldwide enlightenment: targeting cancer’s greasy ball
This article is about Revolution Medicines, a biotech firm targeting a protein called RAS, which drives many cancers (like pancreatic cancer). Unlike older drugs that only work on 'sleeping' RAS, its…
Source: Fund website
15 Jul 2026Aswath Damodaran (Musings on Markets)Article~15 min
Country Risk: Drivers, Measures and Investment Implications - The 2026 Edition!
This article explains that country risk—like political instability or economic crisis—can no longer be avoided by diversifying across countries, because markets crash together in bad times. Valuation…
Source: Fund website
15 Jul 2026Rick Rule (Rule Investment Media)Article~11 min
Rule Symposium highlights 2026 — Rule Investment Newsletter #17
Gold and silver have dropped sharply, but experts at a recent investment conference say this is a healthy pullback in a long-term bull market, not the end. They recommend buying the dip, especially di…
Source: Fund website
15 Jul 2026Akre Capital ManagementQuarterly~17 min
Akre Focus ETF Quarterly Commentary
This quarterly commentary explains why the Akre Focus Fund trailed the S&P 500 badly (up only 0.66% vs 15.20% in Q2) but argues its holdings are in the strongest fundamental shape in a decade. The man…
Source: Fund website
15 Jul 2026Baillie GiffordDeep research~7 min
Monks’ musings: winning the long race
This article explains how the Monks fund picks stocks in the AI boom. They split the market into three groups: AI hardware, digital services, and industrial stocks. Instead of chasing every AI name, t…
Source: Fund website